BONE ANCHORED PORT for Hemodialysis Treatment (BAP)
Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment
Sponsor: Cendres+Métaux
Terminated
This trial was terminated. No reason was provided.
A NA clinical study on End-Stage Renal Disease Requiring Haemodialysis and Hemodialysis Access Failure (Disorder), this trial is terminated or withdrawn. The trial is conducted by Cendres+Métaux and has accumulated 11 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2022 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2021 — Dec 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Sep 2019 [monthly]
Recruiting NA
-
Nov 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Mar 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Mar 2017 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cendres+Métaux
For direct contact, visit the study record on ClinicalTrials.gov .